DK2890384T3 - Lægemiddelleveringsystemer og fremgangsmåder til behandling af blærekræft omfattende oxaliplatin - Google Patents
Lægemiddelleveringsystemer og fremgangsmåder til behandling af blærekræft omfattende oxaliplatin Download PDFInfo
- Publication number
- DK2890384T3 DK2890384T3 DK13765839.9T DK13765839T DK2890384T3 DK 2890384 T3 DK2890384 T3 DK 2890384T3 DK 13765839 T DK13765839 T DK 13765839T DK 2890384 T3 DK2890384 T3 DK 2890384T3
- Authority
- DK
- Denmark
- Prior art keywords
- treatment
- methods
- delivery systems
- bladder cancer
- cancer including
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
- A61M31/002—Devices for releasing a drug at a continuous and controlled rate for a prolonged period of time
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
- A61K31/282—Platinum compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/04—General characteristics of the apparatus implanted
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2210/00—Anatomical parts of the body
- A61M2210/10—Trunk
- A61M2210/1078—Urinary tract
- A61M2210/1085—Bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2210/00—Anatomical parts of the body
- A61M2210/10—Trunk
- A61M2210/1078—Urinary tract
- A61M2210/1089—Urethra
- A61M2210/1096—Male
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2210/00—Anatomical parts of the body
- A61M2210/16—Male reproductive, genital organs
- A61M2210/166—Prostate
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Anesthesiology (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Gynecology & Obstetrics (AREA)
- Reproductive Health (AREA)
- Molecular Biology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nanotechnology (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261696027P | 2012-08-31 | 2012-08-31 | |
| PCT/US2013/057836 WO2014036555A1 (en) | 2012-08-31 | 2013-09-03 | Drug delivery systems and methods for treatment of bladder cancer comprising oxaliplatin |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK2890384T3 true DK2890384T3 (da) | 2022-01-10 |
Family
ID=49226511
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK13765839.9T DK2890384T3 (da) | 2012-08-31 | 2013-09-03 | Lægemiddelleveringsystemer og fremgangsmåder til behandling af blærekræft omfattende oxaliplatin |
Country Status (24)
| Country | Link |
|---|---|
| US (2) | US10543346B2 (da) |
| EP (1) | EP2890384B1 (da) |
| JP (1) | JP6463266B2 (da) |
| KR (1) | KR102157548B1 (da) |
| CN (1) | CN104640549B (da) |
| AU (1) | AU2013308464B2 (da) |
| BR (1) | BR112015003836A2 (da) |
| CA (1) | CA2882319C (da) |
| CY (1) | CY1124890T1 (da) |
| DK (1) | DK2890384T3 (da) |
| ES (1) | ES2902833T3 (da) |
| HR (1) | HRP20211921T1 (da) |
| HU (1) | HUE056976T2 (da) |
| IL (1) | IL237281B (da) |
| IN (1) | IN2015DN01561A (da) |
| LT (1) | LT2890384T (da) |
| MX (1) | MX365688B (da) |
| PL (1) | PL2890384T3 (da) |
| PT (1) | PT2890384T (da) |
| RS (1) | RS62875B1 (da) |
| RU (1) | RU2657591C2 (da) |
| SG (1) | SG11201501424SA (da) |
| SI (1) | SI2890384T1 (da) |
| WO (1) | WO2014036555A1 (da) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8721621B2 (en) | 2009-09-10 | 2014-05-13 | Taris Biomedical, Inc. | Systems and methods for deploying devices to genitourinary sites |
| RU2678308C2 (ru) | 2012-08-31 | 2019-01-25 | ТАРИС Биомедикал ЛЛК | Системы доставки лекарственного средства и способы лечения заболевания предстательной железы, включающие применение гемцитабина |
| EP3157515B1 (en) | 2014-06-23 | 2021-05-26 | Placon Therapeutics, Inc. | Platinum compounds, compositions, and uses thereof |
| CN107810187B (zh) | 2015-07-07 | 2020-09-15 | H.隆德贝克有限公司 | 用于治疗外周疾病的具有咪唑并三嗪酮骨架和咪唑并吡嗪酮骨架的pde9抑制剂 |
| KR102435709B1 (ko) * | 2016-05-06 | 2022-08-25 | 타리스 바이오메디컬 엘엘씨 | 하부 요로 요로상피암을 치료하는 방법 |
| EP3481398A1 (en) | 2016-07-06 | 2019-05-15 | Imara, Inc. | Pde9 inhibitors for treatment of peripheral diseases |
| HRP20240146T1 (hr) | 2017-05-26 | 2024-04-12 | Cardurion Pharmaceuticals, Inc. | Postupci dobivanja i upotrebe inhibitora pde9 |
| SG10201913998YA (en) | 2017-07-25 | 2020-03-30 | Taris Biomedical Llc | Methods of treating tumor metastasis |
| MA50581A (fr) | 2017-11-08 | 2020-09-16 | Taris Biomedical Llc | Méthodes de traitement et de thérapie d'entretien contre le cancer de la vessie faisant appel à de la gemcitabine |
| CN117843645A (zh) | 2018-05-25 | 2024-04-09 | 伊马拉公司 | 一种pde9抑制剂的一水合物和结晶形态 |
| KR20210039403A (ko) | 2018-08-01 | 2021-04-09 | 타리스 바이오메디컬 엘엘씨 | 트로스피움을 사용한 과민성 방광의 치료 방법 |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6171298B1 (en) | 1996-05-03 | 2001-01-09 | Situs Corporation | Intravesical infuser |
| AU2003301669B2 (en) | 2002-10-22 | 2009-04-30 | Biomerix Corporation | Method and system for intravesicular delivery of the therapeutic agents |
| CN1960737A (zh) * | 2004-06-03 | 2007-05-09 | 霍夫曼-拉罗奇有限公司 | 用奥沙利铂和egfr－抑制剂治疗 |
| US8361490B2 (en) | 2004-09-16 | 2013-01-29 | Theracoat Ltd. | Biocompatible drug delivery apparatus and methods |
| US8801694B2 (en) | 2005-08-11 | 2014-08-12 | Massachusetts Institute Of Technology | Intravesical drug delivery device |
| NZ585449A (en) | 2007-12-11 | 2012-07-27 | Massachusetts Inst Technology | Implantable drug delivery device and methods for treatment of the bladder and other body vestcles or lumens |
| CN102065841A (zh) | 2008-04-04 | 2011-05-18 | 里培拉药品公司 | 利用脂质体肉毒杆菌毒素对膀胱功能障碍的治疗 |
| AU2009270849B2 (en) * | 2008-07-17 | 2013-11-21 | Micell Technologies, Inc. | Drug delivery medical device |
| CA2733468C (en) | 2008-08-09 | 2017-12-05 | Massachusetts Institute Of Technology | Implantable drug delivery device and methods of treating male genitourinary and surrounding tissues |
| SG177360A1 (en) * | 2009-06-26 | 2012-02-28 | Taris Biomedical Inc | Implantable drug delivery devices and methods of making the same |
| US9017312B2 (en) | 2009-09-10 | 2015-04-28 | Taris Biomedical Llc | Implantable device for controlled drug delivery |
| PL2512581T3 (pl) | 2009-12-17 | 2021-11-02 | Taris Biomedical Llc | Wszczepiane urządzenie z tolerancją wewnątrzpęcherzową |
| WO2012048114A1 (en) | 2010-10-06 | 2012-04-12 | Taris Biomedical, Inc. | Time-selective bioresorbable or collapsible drug delivery systems and methods |
| WO2012065044A2 (en) | 2010-11-12 | 2012-05-18 | Purdue Research Foundation | Treating bladder tumor cells using fibronectin attachment protein as a target |
| RU2620032C2 (ru) | 2011-01-10 | 2017-05-22 | Аллерган, Инк. | Схема приема лидокаина для применения в продолжительном лечении боли в мочевом пузыре и раздражения при мочеиспускании |
| ES2637388T3 (es) * | 2011-02-04 | 2017-10-13 | Taris Biomedical, Inc. | Dispositivo implantable para la liberación controlada de un fármaco de baja solubilidad |
| RU2678308C2 (ru) | 2012-08-31 | 2019-01-25 | ТАРИС Биомедикал ЛЛК | Системы доставки лекарственного средства и способы лечения заболевания предстательной железы, включающие применение гемцитабина |
| CA2883855C (en) | 2012-09-18 | 2020-09-15 | Taris Biomedical Llc | Drug delivery systems and methods for treatment of bladder voiding dysfunction|and other lower urinary tract disorders by using trospium |
| BR112015022433B1 (pt) | 2013-03-15 | 2022-06-21 | Taris Biomedical Llc | Dispositivo de liberação de droga intravesical |
| PT3035991T (pt) | 2013-08-19 | 2020-10-06 | Taris Biomedical Llc | Métodos e dispositivos de unidades múltiplas para administração de fármacos |
-
2013
- 2013-09-03 EP EP13765839.9A patent/EP2890384B1/en active Active
- 2013-09-03 AU AU2013308464A patent/AU2013308464B2/en not_active Ceased
- 2013-09-03 SG SG11201501424SA patent/SG11201501424SA/en unknown
- 2013-09-03 SI SI201331961T patent/SI2890384T1/sl unknown
- 2013-09-03 ES ES13765839T patent/ES2902833T3/es active Active
- 2013-09-03 JP JP2015530138A patent/JP6463266B2/ja active Active
- 2013-09-03 PT PT137658399T patent/PT2890384T/pt unknown
- 2013-09-03 CN CN201380044244.3A patent/CN104640549B/zh active Active
- 2013-09-03 RS RS20220054A patent/RS62875B1/sr unknown
- 2013-09-03 RU RU2015109296A patent/RU2657591C2/ru active
- 2013-09-03 BR BR112015003836A patent/BR112015003836A2/pt not_active Application Discontinuation
- 2013-09-03 PL PL13765839T patent/PL2890384T3/pl unknown
- 2013-09-03 CA CA2882319A patent/CA2882319C/en active Active
- 2013-09-03 DK DK13765839.9T patent/DK2890384T3/da active
- 2013-09-03 LT LTEPPCT/US2013/057836T patent/LT2890384T/lt unknown
- 2013-09-03 WO PCT/US2013/057836 patent/WO2014036555A1/en active Application Filing
- 2013-09-03 HU HUE13765839A patent/HUE056976T2/hu unknown
- 2013-09-03 MX MX2015002325A patent/MX365688B/es active IP Right Grant
- 2013-09-03 KR KR1020157007349A patent/KR102157548B1/ko active IP Right Grant
- 2013-09-03 HR HRP20211921TT patent/HRP20211921T1/hr unknown
-
2015
- 2015-02-17 IL IL237281A patent/IL237281B/en active IP Right Grant
- 2015-02-23 US US14/628,900 patent/US10543346B2/en not_active Expired - Fee Related
- 2015-02-25 IN IN1561DEN2015 patent/IN2015DN01561A/en unknown
-
2019
- 2019-12-16 US US16/715,857 patent/US11007355B2/en active Active
-
2022
- 2022-01-05 CY CY20221100014T patent/CY1124890T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL269877B (en) | Methods and systems for pumping blood | |
| DK2890384T3 (da) | Lægemiddelleveringsystemer og fremgangsmåder til behandling af blærekræft omfattende oxaliplatin | |
| DK3033086T3 (da) | Kombinationsterapi til behandling af cancer | |
| DK2716291T3 (da) | Kombination af opioider og anticancer-lægemidler til cancerbehandling | |
| DK2897620T3 (da) | Fremgangsmåde til behandling af cancer | |
| BR112015032392A2 (pt) | sistemas e métodos de entrega de terapia usando um dispositivo médico ambulatorial | |
| DK2838900T3 (da) | Forbindelser og fremgangsmåder til antiviral behandling | |
| DK3329884T3 (da) | Implanterbar indretning til behandling af glaukom | |
| EP2856421A4 (en) | SYSTEMS AND METHODS FOR TRANSPARENT MEDICAL TREATMENT DELIVERY | |
| DK2818482T3 (da) | Farmaceutisk sammensætning til behandling af cancer | |
| DK2818481T3 (da) | Farmaceutisk sammensætning til behandling og/eller forebyggelse af cancer | |
| DK2824114T3 (da) | Farmaceutisk sammensætning til behandling af cancer | |
| DK3311845T3 (da) | Terapeutiske polymernanopartikler og fremgangsmåder til fremstilling og anvendelse heraf | |
| DK3076976T3 (da) | Fremgangsmåder til behandling af cancer | |
| DK2764881T3 (da) | System til medicinsk behandling | |
| KR20180084772A (ko) | 암 치료를 위한 조합 치료법 | |
| DK2790738T3 (da) | Biomarkører for kollateral geninaktivering og mål for cancerterapi | |
| DK2861273T3 (da) | Anvendelse af heparin og kulhydrater til behandling af cancer. | |
| IL247347A0 (en) | Systems and methods for administering drugs to treat bladder cancer using gemcitabine | |
| DK3089749T3 (da) | Kombinerede præparater til behandling af cancer | |
| DK2825558T3 (da) | Kombinationsterapi til behandling af ovariecancer | |
| HK1222548A1 (zh) | 治療惡性腫瘤的藥物組合 | |
| DK3290035T3 (da) | Procaspase-kombinationsterapi til behandling af cancer | |
| DK2802351T3 (da) | Midler til behandling af triple-negativ brystkræft | |
| DK2842006T3 (da) | System og fremgangsmåde til kontrollerende koblede leverings spiraler |